$JBL

JBL Stock Rises as Goldman Sachs Backs AI Growth Story

Jabil Inc. (JBL) stock rose 5.65% after strong earnings guidance. Goldman Sachs, while cutting its target to $375, expects 50% AI revenue growth and 6% EBIT margins. JBL reported $8.75B revenue, $275M net income, and 3% profit margin. The stock is in an uptrend, with support at $300 and resistance around $340.

Original reporting
Published Sep 11, 2026, 8:48 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 12, 2026, 9:21 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
JBL Stock Rises as Goldman Sachs Backs AI Growth Story — source image
Decision brief

The 30-second read

$JBLBullishMed
01

Why it matters

The guidance lift provides a concrete catalyst for short‑term traders.

02

Market read

Guidance-driven rally may influence related hardware manufacturers and AI supply chain stocks.

03

What to watch

Leverage ratio remains elevated; any slowdown in capital spending could hurt cash flow.

Relevance 7/10Novelty 7/10Timing: ahead of FY26 Q4 earnings release

Background

Jabil is a leading contract manufacturer; Goldman Sachs recently cut its price target but still sees upside.

Company-level read

Ticker impact

$JBLBullishHigh confidence
Context

Jabil Inc. shares rose 5.65% on fresh earnings guidance indicating higher AI revenue and margin expansion.

Expected impact

Expect further upside toward $340 if guidance holds.

Evidence & confidence

Guidance is new, quantitative, and aligns with analyst sentiment; price already trending higher.

Market effects

Positive AI revenue outlook may lift other EMS/ODM peers.

U.S. tech manufacturing sector sees modest boost.

AI-driven demand signals broader tech supply chain strength.

Counterpoint

If AI mix shift stalls, high valuation multiples could pressure the stock.

Key entities

  • Jabil Inc.

    Diversified EMS/ODM vendor

  • Goldman Sachs

    Provides target and AI revenue outlook

Related articles

$JBLMed

Why Jabil (JBL) Shares Are Plunging Today

Jabil (JBL) shares fell 5.1% after Goldman Sachs lowered its price target to $375, citing a more cautious valuation. The stock is volatile, down 22% from its 52-week high, but up 25.1% year-to-date. Higher bond yields and oil prices pose risks for the company.

$JBLMedAI 8/10

Jabil Rises 36.2% Year to Date: Should You Buy the Stock?

Jabil Inc. (JBL) has risen 36.2% year-to-date, outperforming its industry and the S&P 500. The company expects AI-related revenues to reach $13.6B in fiscal 2026, up from $9B in 2025, and is expanding manufacturing capacity to meet demand. JBL also sees growth in healthcare, renewable energy, and digital commerce sectors, but faces supply chain and competition challenges.

$JBLHighAI 8/10

FDA Contamination Warning Could Be A Game Changer For Jabil’s (JBL) Pharma Ambitions

The FDA issued a warning to Jabil's Pharmaceutics International facility, citing significant violations of sterile drug manufacturing practices, including fungal contamination and weak quality oversight. This raises concerns about Jabil's ability to manufacture sterile products and could impact its pharmaceutical expansion plans. Jabil's 2026 revenue guidance of $35 billion includes contributions from healthcare and pharma, which may now be questioned by investors.

$JBLHighAI 8/10

Jabil Stock: Is Wall Street Bullish or Bearish?

Jabil Inc. (JBL), a $33.8B electronic manufacturing services provider, reported Q3 2026 adjusted EPS of $3.16 and revenue of $8.75B, exceeding expectations. The company raised its fiscal 2026 guidance, citing strong AI data-center demand and new partnerships. Shares have surged 58.6% over 52 weeks, outperforming the S&P 500. Analysts rate it a 'Strong Buy' with a mean price target of $451.18.

$JBLMed

Jabil upgraded by UBS as AI demand, healthcare growth support outlook

UBS upgraded Jabil Inc (JBL) to Buy and raised estimates, saying a multiyear growth cycle is supported by AI investment, healthcare demand, and expanding automation and robotics. UBS set a $430 price target and lowered its valuation multiple to about 22x. It forecasts AI revenue growth to about $20.3B in FY2027, raised EPS to $16.78 (FY2027) and $20.24 (FY2028).

$JBLMed

Stocks making the biggest moves midday: Jabil, AppLovin, Apollo, SpaceX, Upwork & more

Midday movers included Jabil, up 5% after a UBS upgrade to Buy, and AppLovin, down 5% after Bank of America downgraded to neutral and cut its price target to $400. Aramark rose 9% after Q3 beat and raised forecast. Under Armour fell 8% on a Barclays downgrade. Upwork dropped 13% on weaker guidance. Fermi jumped 22% after a first binding lease with TensorWave for 222 MW and about $6.5B contracted revenue.